This finding is in line with previously published works, where both Badve and colleagues and Habashy and colleagues also demonstrated that FOXA1 expression is able to significantly predict a better survival for breast cancer patients [10,33], although the multivariate analysis showed that it is not an independent prognostic marker, exactly as shown for ER. This evidence concerns the gene FOXA1 and breast carcinoma.